Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 9, 2009, Pages 796-803

  Feng, C Y ^a,b   Li, Q T ^a   Zhang, X Y ^a   Dong, K ^a   Hu, B Y ^a   Guo, X K ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immune strategy; Leptospira; Lipoproteins LipL32 and LipL41; Recombinant vaccine

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; LEPTOSPIROSIS VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN LIPL32 41 OMPL1 VACCINE; OUTER MEMBRANE PROTEIN LIPL32 VACCINE; PLASMID VECTOR; PLASMID VECTOR VAX1; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DNA HYBRIDIZATION; DNA IMMUNIZATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LEPTOSPIRA; MICROSCOPY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; SPLEEN CELL;

LEPTOSPIRA; MUS;

EID: 71049134446     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009005000013     Document Type: Article

References (30)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3: 757-771. (Pubitemid 37489960)
2. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, et al. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 2000; 68: 2276-2285. (Pubitemid 30164865)
3. Faisal SM, Yan W, McDonough SP, Chang YF. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 2009; 27: 378-387.
4. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003; 422: 888-893. (Pubitemid 36520040)
5. Nascimento AL, Verjovski-Almeida S, Van Sluys MA, Monteiro-Vitorello CB, Camargo LE, Digiampietri LA, et al. Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 2004; 37: 459-477. (Pubitemid 38618543)
6. Haake DA, Walker EM, Blanco DR, Bolin CA, Miller MN, Lovett MA. Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation. Infect Immun 1991; 59: 1131-1140.
7. Shang ES, Summers TA, Haake DA. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 1996; 64: 2322-2330.
8. Haake DA, Matsunaga J. Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun 2002; 70: 4936-4945. (Pubitemid 34907303)
9. Haake DA, Martinich C, Summers TA, Shang ES, Pruetz JD, McCoy AM, et al. Characterization of leptospiral outer membrane lipoprotein LipL36: downregulation associated with late-log-phase growth and mammalian infection. Infect Immun 1998; 66: 1579-1587. (Pubitemid 128471521)
10. Cullen PA, Haake DA, Bulach DM, Zuerner RL, Adler B. LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 2003; 71: 2414-2421. (Pubitemid 36519852)
11. Nally JE, Artiushin S, Timoney JF. Molecular characterization of thermoinduced immunogenic proteins Q1p42 and Hsp15 of Leptospira interrogans. Infect Immun 2001; 69: 7616-7624. (Pubitemid 33086590)
12. Dong H, Hu Y, Xue F, Sun D, Ojcius DM, Mao Y, et al. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol 2008; 8: 223.
13. Matsunaga J, Young TA, Barnett JK, Barnett D, Bolin CA, Haake DA. Novel 45-kilodalton leptospiral protein that is processed to a 31-kilodalton growth-phase-regulated peripheral membrane protein. Infect Immun 2002; 70: 323-334. (Pubitemid 34028632)
14. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, et al. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 2007; 26: 88-95. (Pubitemid 350213201)
15. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999; 67: 6572-6582.
16. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468. (Pubitemid 20145055)
17. Mor G, Eliza M. Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity. Mol Biotechnol 2001; 19: 245-250. (Pubitemid 33063506)
18. Alpar HO, Bramwell VW. Current status of DNA vaccines and their route of administration. Crit Rev Ther Drug Carrier Syst 2002; 19: 307-383.
19. Stevenson FK, Ottensmeier CH, Johnson P, Zhu D, Buchan SL, McCann KJ, et al. DNA vaccines to attack cancer. Proc Natl Acad Sci U S A 2004; 101 (Suppl 2): 14646-14652.
20. Barouch DH, Santra S, Steenbeke TD, Zheng XX, Perry HC, Davies ME, et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol 1998; 161: 1875-1882. (Pubitemid 28387609)
21. Zhao P, Cao J, Zhao LJ, Qin ZL, Ke JS, Pan W, et al. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. Virology 2005; 331: 128-135. (Pubitemid 39593638)
22. Li QT, Zhu YZ, Chu JY, Dong K, He P, Feng CY, et al. Granulocyte- macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine. Acta Pharmacol Sin 2006; 27: 1487-1494. (Pubitemid 44630318)
23. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, et al. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 2005; 73: 4062-4069. (Pubitemid 40923146)
24. Merien F, Baranton G, Perolat P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 1997; 65: 729-738. (Pubitemid 27053246)
25. Gor DO, Rose NR, Greenspan NS. TH1-TH2: a procrustean paradigm. Nat Immunol 2003; 4: 503-505.
26. Doria-Rose NA, Haigwood NL. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 2003; 31: 207-216.
27. Williamson ED, Bennett AM, Perkins SD, Beedham RJ, Miller J, Baillie LW. Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine 2002; 20: 2933-2941. (Pubitemid 34785964)
28. Silva EF, Santos CS, Athanazio DA, Seyffert N, Seixas FK, Cerqueira GM, et al. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 2008; 26: 3892-3896.
29. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 2008; 26: 277-287. (Pubitemid 350266122)
30. Choy HA, Kelley MM, Chen TL, Moller AK, Matsunaga J, Haake DA. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun 2007; 75: 2441-2450. (Pubitemid 46744335)